Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY6 | Q15077 | 9/20 | 0.41 |
| ▸ | P2RY2 | P41231 | 7/20 | 0.41 |
| ▸ | POLA1 | P09884 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | POLD1 | P28340 | 1/20 | 0.40 |
| ▸ | P2RY4 | P51582 | 5/20 | 0.39 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.36 |
| ▸ | DTYMK | P23919 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4010795 | 0.87 | P2RY6 (0.41) | P2RY6P2RY2POLA1POLBPOLD1 | |
| SCHEMBL886859 | 0.85 | POLG (0.41) | P2RY6P2RY2P2RY4P2RX3 | |
| SCHEMBL6514738 | 0.84 | P2RY2 (0.44) | P2RY6P2RY2POLA1POLBPOLD1 | |
| SCHEMBL5191085 | 0.81 | POLB (0.50) | P2RY6P2RY2POLA1POLBPOLD1 | |
| SCHEMBL7760372 | 0.81 | TK1 (0.35) | — | |
| SCHEMBL5708922 | 0.80 | POLG (0.48) | P2RY6P2RY2POLBP2RY4 | |
| SCHEMBL5285301 | 0.77 | POLB (0.48) | P2RY6P2RY2POLA1POLBPOLD1 | |
| SCHEMBL5188713 | 0.76 | POLB (0.45) | P2RY6P2RY2POLA1POLBPOLD1 | |
| SCHEMBL7520080 | 0.76 | P2RY2 (0.35) | P2RY6P2RY2POLA1P2RY4P2RX3 | |
| SCHEMBL3715513 | 0.76 | POLB (0.51) | P2RY6P2RY2POLA1POLBPOLD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050214759-A1 | Enzymatic redox labelling of nucleic acids | WLASSOF WJATSCHESSLAW | 2005-09-29 | — | — | US | claimed |
| EP-1468006-A1 | ENZYMATIC REDOX LABELLING OF NUCLEIC ACIDS | UNISEARCH LIMITED (AU) | 2004-10-20 | — | — | EP | claimed |
| WO-2003055898-A1 | ENZYMATIC REDOX LABELLING OF NUCLEIC ACIDS | UNISEARCH LIMITED (AU) | 2003-07-10 | — | — | WO | claimed |
| US-12584168-B2 | Sample preparation method | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2026-03-24 | — | — | US | disclosed |
| US-20250313889-A1 | SAMPLE PREPARATION METHOD | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2025-10-09 | — | — | US | disclosed |
| US-20230250474-A1 | SAMPLE PREPARATION METHOD | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2023-08-10 | — | — | US | disclosed |
| US-11542551-B2 | Sample preparation method | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2023-01-03 | — | — | US | disclosed |
| US-20200318179-A1 | SAMPLE PREPARATION METHOD | OXFORD NANOPORE TECHNOLOGIES LTD. (GB) | 2020-10-08 | — | — | US | disclosed |
| US-10669578-B2 | Sample preparation method | OXFORD NANOPORE TECHNOLOGIES LTD. (GB) | 2020-06-02 | — | — | US | disclosed |
| EP-3108010-B1 | SAMPLE PREPARATION METHOD | OXFORD NANOPORE TECH LTD (GB) | 2018-11-28 | — | — | EP | disclosed |
| EP-1725572-B1 | MACROMOLECULAR NUCLEOTIDE COMPOUNDS AND METHODS FOR USING THE SAME | AGCT GMBH (DE) | 2017-05-31 | — | — | EP | disclosed |
| US-20100093992-A1 | Macromolecular Nucleotide Compounds and Methods for Using the Same | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 2010-04-15 | — | — | US | disclosed |
| US-20100029494-A1 | Macromolecular Nucleotide Compounds And Methods For Using The Same | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 2010-02-04 | — | — | US | disclosed |
| EP-2074133-A2 | COMPONENTS AND METHOD FOR ENZYMATIC SYNTHESIS OF NUCLEIC ACIDS | Genovoxx GmbH (DE) | 2009-07-01 | — | — | EP | disclosed |
| WO-2008043426-A2 | COMPONENTS AND METHOD FOR ENZYMATIC SYNTHESIS OF NUCLEIC ACIDS | GENOVOXX GMBH (DE) | 2008-04-17 | — | — | WO | disclosed |
| EP-1885876-A2 | MACROMOLECULAR NUCLEOTIDE LINKS AND METHODS FOR THEIR USE | Genovoxx GmbH (DE) | 2008-02-13 | — | — | EP | disclosed |
| EP-1725572-A2 | MACROMOLECULAR NUCLEOTIDE COMPOUNDS AND METHODS FOR USING THE SAME | Genovoxx GmbH (DE) | 2006-11-29 | — | — | EP | disclosed |
| WO-2006097320-A2 | MACROMOLECULAR NUCLEOTIDE LINKS AND METHODS FOR THEIR USE | GENOVOXX GMBH (DE) | 2006-09-21 | — | — | WO | disclosed |
| US-20050214759-A1 | Enzymatic redox labelling of nucleic acids | WLASSOF WJATSCHESSLAW | 2005-09-29 | — | — | US | disclosed |
| WO-2005044836-A2 | MACROMOLECULAR NUCLEOTIDE COMPOUNDS AND METHODS FOR USING THE SAME | GENOVOXX GMBH (DE) | 2005-05-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12584168-B2 | Sample preparation method | POLN, POLRMT, POLM | P2RY6 259/4885P2RY2 181/4885POLA1 19/4885 |
| US-20100093992-A1 | Macromolecular Nucleotide Compounds and Methods for Using the Same | NCL, PNP, NUDT1 | P2RY6 832/4885P2RY2 941/4885POLA1 110/4885 |
| US-20100029494-A1 | Macromolecular Nucleotide Compounds And Methods For Using The Same | DUT, SAMHD1, PNP | P2RY6 1071/4885P2RY2 1513/4885POLA1 75/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.